Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.73 |
| ▸ | NPC1 | O15118 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 2/20 | 0.73 |
| ▸ | CASP1 | P29466 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.73 |
| ▸ | CASP7 | P55210 | 2/20 | 0.73 |
| ▸ | POLB | P06746 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 7/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | AURKA | O14965 | 2/20 | 0.49 |
| ▸ | PIM1 | P11309 | 2/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.49 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30646327 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL824397 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL30704451 | 1.00 | SMN1; SMN2 (0.73) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL29572859 | 0.85 | RAB9A (1.00) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL278729 | 0.85 | RAB9A (1.00) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL16740696 | 0.76 | SMN1; SMN2 (0.59) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL16196330 | 0.76 | KDM4E (0.43) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL17274958 | 0.75 | SMN1; SMN2 (0.53) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| Anthraquinone SCHEMBL4660434 | 0.75 | RAB9A (0.78) | SMN1; SMN2NPC1TP53CASP1RAB9A | |
| SCHEMBL4505367 | 0.75 | TDO2 (0.53) | SMN1; SMN2NPC1TP53CASP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023249965-A1 | BENZOCARBAZOLE DERIVATIVES AS INHIBITORS OF DRP1 | ASHA THERAPEUTICS LLC (US) | 2023-12-28 | — | — | WO | disclosed |
| EP-3261759-B1 | SELF-HEALING CAPACITOR AND METHODS OF PRODUCTION THEREOF | CAPACITOR SCIENCES INC (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10347423-B2 | Solid multilayer structure as semiproduct for meta-capacitor | CAPACITOR SCIENCES INCORPORATED (US) | 2019-07-09 | — | — | US | disclosed |
| US-RE47117-E1 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX K.K. (JP) | 2018-11-06 | — | — | US | disclosed |
| US-20180114641-A1 | SOLID MULTILAYER STRUCTURE AS SEMIPRODUCT FOR META-CAPACITOR | CAPACITOR SCIENCES INCORPORATED | 2018-04-26 | — | — | US | disclosed |
| US-20180114641-A1 | SOLID MULTILAYER STRUCTURE AS SEMIPRODUCT FOR META-CAPACITOR | CAPACITOR SCIENCES INCORPORATED | 2018-04-26 | — | — | US | disclosed |
| US-9916931-B2 | Energy storage devices and methods of production thereof | CAPACITOR SCIENCE INCORPORATED (US) | 2018-03-13 | — | — | US | disclosed |
| US-9916931-B2 | Energy storage devices and methods of production thereof | CAPACITOR SCIENCE INCORPORATED (US) | 2018-03-13 | — | — | US | disclosed |
| US-9852846-B2 | Self-healing capacitor and methods of production thereof | CAPACITOR SCIENCES INCORPORATED (US) | 2017-12-26 | — | — | US | disclosed |
| US-9852846-B2 | Self-healing capacitor and methods of production thereof | CAPACITOR SCIENCES INCORPORATED (US) | 2017-12-26 | — | — | US | disclosed |
| US-20100118241-A1 | Liquid Crystal Display Operating in a Vertically Aligned Mode | CRYSOPTIX KK (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-1984373-B1 | 6,7-DIHYDROBENZIMIDAZO[1 ,2-C]QUINAZOLIN-6-ONE CARBOXYLIC ACIDS, THEIR ESTERS, AND METHODS OF SYNTHESIS THEREOF | CRYSOPTIX KK (JP) | 2010-03-17 | — | — | EP | disclosed |
| US-20100047477-A1 | 6,7-Dihydrobenzimidazo[1,2-c]Quinazolin-6-One Carboxylic Acids, their Esters, and Methods of Synthesis Thereof | CRYSOPTIX KK (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20090268136-A1 | Color Liquid Crystal Display and Compensation Panel | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090268136-A1 | Color Liquid Crystal Display and Compensation Panel | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20090161037-A1 | Backlight Module and Liquid Crystal Display Incorporating the Same | CRYSOPTIX KK (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090161037-A1 | Backlight Module and Liquid Crystal Display Incorporating the Same | CRYSOPTIX KK (JP) | 2009-06-25 | — | — | US | disclosed |
| WO-2009037565-A2 | COLOUR LIQUID CRYSTAL DISPLAY AND PATTERNED COMPENSATION PANEL | CRYSOPTIX K.K. (GB) | 2009-03-26 | — | — | WO | disclosed |
| EP-1984373-A1 | 6,7-DIHYDROBENZIMIDAZO[1 ,2-C]QUINAZOLIN-6-ONE CARBOXYLIC ACIDS, THEIR ESTERS, AND METHODS OF SYNTHESIS THEREOF | CRYSOPTIX K.K. (JP) | 2008-10-29 | — | — | EP | disclosed |
| WO-2007080420-A1 | 6,7-DIHYDROBENZIMIDAZO[1 ,2-C]QUINAZOLIN-6-ONE CARBOXYLIC ACIDS, THEIR ESTERS, AND METHODS OF SYNTHESIS THEREOF | CRYSOPTIX K.K. (JP) | 2007-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100047477-A1 | 6,7-Dihydrobenzimidazo[1,2-c]Quinazolin-6-One Carboxylic Acids, their Esters, and Methods of Synthesis Thereof | SCN7A, CA7, HCN3 | SMN1; SMN2 3703/4885NPC1 431/4885TP53 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.